Evidence map›Paper›PMID 32832623›Full record

ArticleScience advances2020

Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4

Dawei Zhou, Tsuyoshi Hayashi, Maxime Jean, Weili Kong, Guillaume Fiches, Ayan Biswas, Shuai Liu, Hailemichael O Yosief, Xiaofeng Zhang, Jay Bradner and 4 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Dawei ZhouDepartment of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA.ORCID 0000-0002-0814-3191
Tsuyoshi HayashiDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester NY 14642, USA.ORCID 0000-0003-3158-673X
Maxime JeanDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester NY 14642, USA.
Weili KongDepartment of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA.ORCID 0000-0002-9104-7730
Guillaume FichesDepartment of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA.ORCID 0000-0003-3515-8417
Ayan BiswasDepartment of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA.ORCID 0000-0002-6028-2033
Shuai LiuChemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA.
Hailemichael O YosiefChemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA.ORCID 0000-0003-2907-7688
Xiaofeng ZhangChemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA.ORCID 0000-0003-4529-1158
Jay BradnerNovartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.ORCID 0000-0003-1422-5318
Jun QiDana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-1461-3356
Wei ZhangChemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA.ORCID 0000-0002-6097-2763
Netty SantosoDepartment of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA.ORCID 0000-0003-1175-5831
Jian ZhuDepartment of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA.ORCID 0000-0001-9856-8320
The Ohio State University · USUniversity of Massachusetts Boston · USUniversity of Rochester · USDana-Farber Cancer Institute · USNovartis (United States) · US

Funding

U Mass Boston / DFHCC U54 Partnership (1 of 2)U54CA156732 · NCI · DANA-FARBER CANCER INST · PI Shoba Ramanadhan · 2010 to 2026
$25.6M
Cancer Chemical Biology and Metabolism Training ProgramT32CA236754 · NCI · DANA-FARBER CANCER INST · PI Nika N Danial, THOMAS M ROBERTS · 2019 to 2026
$2.6M
Investigation of Latency Promoting Genes (LPGs) in HIV Oral Reservoir CellsR01DE025447 · NIDCR · UNIVERSITY OF ROCHESTER · PI ZHU, JIAN · 2015 to 2019
$1.9M
Cooperation of BRD4 and TAT Associated Proteins in HIV Transcription and LatencyR33AI116180 · NIAID · UNIVERSITY OF ROCHESTER · PI ZHU, JIAN · 2016 to 2018
$1.2M
Inhibition of TIP60 by Latent Gammaherpesviruses in B-cell LymphomasR03DE029716 · NIDCR · OHIO STATE UNIVERSITY · PI SANTOSO, NETTY G · 2020 to 2021
$312k
Role of FACT Proteins in Regulating HIV Transcription and LatencyR01AI150448 · NIAID · OHIO STATE UNIVERSITY · PI ZHU, JIAN · 2019 to 2019
$300k
NCI NIH HHS T32 CA236754NCI NIH HHS U54 CA156732NIAID NIH HHS R01 AI150448NIAID NIH HHS R33 AI116180NIDCR NIH HHS R01 DE025447NIDCR NIH HHS R03 DE029716
6 · The paper itself

Abstract

Although combination antiretroviral therapy is effective in controlling HIV-1 infection, latent HIV-1 proviruses cannot be eliminated. HIV-1 reactivation induced by the mere use of latency-reversing agents is insufficient to render death of reservoir cells, indicating that certain intrinsic survival mechanisms exist. We report that Polo-like kinase 1 (PLK1) plays a critical role in survival of CD4

Indexed as

CD4-Positive T-LymphocytesCell Cycle ProteinsHIV InfectionsProtein Serine-Threonine KinasesProto-Oncogene ProteinsHIV-1HumansPolo-Like Kinase 1Virus ActivationVirus LatencyCell Cycle ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene Proteins

Identifiers

PMID32832623
PMCPMC7439358
OpenAlexW3043169190

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.